LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in LianBio as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −4 vs. Q3 2022
- Shares held
- 81.3M
- −2.76M (−3.3%) vs. Q3 2022
- Total value
- $133.3M
- −$34.7M (−20.7%) vs. Q3 2022
- New holders
- 7
- 8 more added
- Sold out
- 11
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 10 | $0 | 0.00% | +10 | New |
| Cary Street Partner Investment Advisory LLC | 1,000 | $1.64K | 0.00% | +1,000 | New |
| Morgan Stanley | 1,001 | $1.64K | 0.00% | −54,145−98.2% | Reduced |
| UBS Group AG | 4,024 | $6.60K | 0.00% | +2,777+222.7% | Added |
| Tower Research Capital LLC (TRC) | 8,519 | $14.0K | 0.00% | −12,254−59.0% | Reduced |
| Commonwealth Equity Services, LLC | 10,830 | $17.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12,532 | $20.6K | 0.00% | +4,355+53.3% | Added |
| Virtu Financial LLC | 17,456 | $29.0K | 0.00% | +17,456 | New |
| Gsa Capital Partners LLP | 19,482 | $32.0K | 0.00% | −106,490−84.5% | Reduced |
| Stifel Financial Corp | 21,250 | $34.9K | 0.00% | +21,250 | New |
| Vident Investment Advisory, LLC | 28,616 | $46.9K | 0.00% | 00.0% | Unchanged |
| Old Well Partners, LLC | 32,200 | $52.8K | 0.05% | 00.0% | Unchanged |
| Jane Street Group, LLC | 47,583 | $78.0K | 0.00% | +47,583 | New |
| HighTower Advisors, LLC | 48,500 | $80.0K | 0.00% | +9,500+24.4% | Added |
| Tang Capital Management LLC | 59,600 | $97.7K | 0.01% | +59,600 | New |
| Victory Capital Management Inc | 64,506 | $105.8K | 0.00% | −108,954−62.8% | Reduced |
| Thrivent Financial for Lutherans | 81,168 | $133.0K | 0.00% | +209+0.3% | Added |
| Manufacturers Life Insurance Company, The | 117,484 | $182.1K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 128,728 | $211.1K | 0.00% | −139,672−52.0% | Reduced |
| MYDA Advisors LLC | 135,000 | $221.4K | 0.16% | +15,000+12.5% | Added |
| 22NW, LP | 141,223 | $231.6K | 0.13% | 00.0% | Unchanged |
| Citadel Advisors LLC | 142,193 | $233.2K | 0.00% | −697,976−83.1% | Reduced |
| Cornercap Investment Counsel Inc | 165,718 | $271.8K | 0.05% | +83,888+102.5% | Added |
| Innovis Asset Management LLC | 176,192 | $289.0K | 0.13% | +176,192 | New |
| TD Asset Management Inc | 178,519 | $292.8K | 0.00% | 00.0% | Unchanged |
| Casdin Capital, LLC | 206,415 | $338.5K | 0.03% | 00.0% | Unchanged |
| Logos Global Management LP | 280,000 | $459.2K | 0.05% | −27,908−9.1% | Reduced |
| Renaissance Technologies LLC | 290,622 | $477.0K | 0.00% | −24,378−7.7% | Reduced |
| Millennium Management LLC | 320,518 | $526.0K | 0.00% | +110,128+52.3% | Added |
| Affinity Asset Advisors, LLC | 650,000 | $1.07M | 0.49% | +100,000+18.2% | Added |
| Citigroup Inc | 707,336 | $1.16M | 0.00% | 00.0% | Unchanged |
| SCHF (Gpe), LLC | 937,500 | $1.54M | 2.99% | 00.0% | Unchanged |
| BlackRock Inc. | 1,023,107 | $1.68M | 0.00% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,032,084 | $1.69M | 0.00% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 2,282,084 | $3.74M | 5.03% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,681,497 | $4.40M | 0.00% | −141,360−5.0% | Reduced |
| Tybourne Capital Management (HK) Ltd | 3,303,573 | $5.42M | 0.54% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,564,173 | $5.85M | 0.03% | 00.0% | Unchanged |
| VR Adviser, LLC | 4,793,047 | $7.86M | 1.32% | −585,294−10.9% | Reduced |
| Perceptive Advisors LLC | 57,558,451 | $94.4M | 2.72% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −713,743−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −429,186−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −206,497−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −58,490−100.0% | Sold out |
| Powell Investment Advisors, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −23,245−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −19,606−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,157−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,650−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −178−100.0% | Sold out |